Adopting an approach that encourages continued progress while simultaneously acknowledging short-term obstacles, the Healthcare Information and Management Systems Society (HIMSS) recommends launching Stage 2 Meaningful Use on-schedule and extending Year 1 of the Meaningful Use Stage 2 attestation period through April 2015 and June 2015 for eligible hospitals (EHs) and eligible professionals (EPs), respectively.  This would encompass 18 months in which EHs and EPs can attest to Meaningful Use requirements for one quarter.

Users of linear accelerator, Versa HD, can now bring target immobilization to new levels through automated gating with Active Breathing Coordinator. For anatomies affected by respiratory motion, such as lung, liver and breast, Active Breathing Coordinator provides non-invasive, internal immobilization of the target, triggering radiation delivery when anatomy is immobilized.

Baptist Health eliminated 85 percent of CDs by storing and sharing medical images in real-time through Accelarad’s secure cloud platform. As central Alabama’s healthcare leader and one of only five Level II trauma facilities in the state, Baptist Health has been an Accelarad customer since March 2013.

 

Frost & Sullivan has named Siemens Healthcare the "2013 North American Interventional Radiology Company of the Year" for its interventional imaging solutions in cardiology, radiology and hybrid surgery. The Frost & Sullivan study states, "Siemens is extremely well positioned within the interventional cardiology segment, within the overarching surgical clinical segment, as well as neurology, oncology and pediatrics." 

Siemens says it has been able to sustain market expansion momentum by continually leading the industry in the development of new technology for high-end interventional equipment, while enhancing current clinical applications and enabling new ones. Over the last decade, Siemens said it has succeeded in establishing the company as the market and technology leader in the United States by exploring new possibilities to enhance interventional therapy and patient care. 

August 22, 2013 — Hologic Inc. announced the commercialization of Horizon, a redesigned DXA (dual-energy X-ray absorptiometry) imaging system for the assessment of three critical health problems — osteoporosis, cardiovascular disease and obesity.

Horizon DXA imaging system

August 22, 2013 — The American Society of Nuclear Cardiology (ASNC) has recently released an online education program for physicians and technologists involved in the practice of nuclear cardiology. This program offers continuing education credits and provides valuable quality control procedures and radiation safety information.

Molecular Targeting Technologies Inc. (MTTI) announced Dr. Kai Chen of the University of Southern California was awarded the 2013 Center for Molecular Imaging Innovation and Translation (CMIIT) Young Investigator Award during the annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) in Vancouver, Canada. Chen presented results from his study entitled: “Synthesis and evaluation of a novel bis (zinc(II)-dipicolyamine) derivative for dual-modality PET/NIRF [positron emission tomography/near-infrared flourescence] imaging of phosphatidylserine exposure.”


Proton therapy, using high-energy subatomic particles, may offer a precise, organ-sparing treatment option for children with high-risk forms of neuroblastoma. For patients in a new study of advanced radiation treatment, proton therapy spared the liver and kidneys from unwanted radiation, while zeroing in on its target.

Carestream Health and the Buffalo Bills have entered into an agreement that will aid Carestream’s development of advanced medical imaging technology designed to help with earlier detection and monitoring of brain injuries.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now